Severity, criticality, and fatality of the SARS-CoV-2 Beta variant
- Abu-Raddad, Laith J
- Chemaitelly, Hiam
- Ayoub, Houssein H
- Yassine, Hadi M
- Benslimane, Fatiha M
- Al Khatib, Hebah A
- Tang, Patrick
- Hasan, Mohammad R
- Coyle, Peter
- AlMukdad, Sawsan
- Al Kanaani, Zaina
- Al Kuwari, Einas
- Jeremijenko, Andrew
- Kaleeckal, Anvar Hassan
- Latif, Ali Nizar
- Shaik, Riyazuddin Mohammad
- Abdul Rahim, Hanan F
- Nasrallah, Gheyath K
- Al Kuwari, Mohamed Ghaith
- Butt, Adeel A
- Al Romaihi, Hamad Eid
- Al-Thani, Mohamed H
- Al Khal, Abdullatif
- Bertollini, Roberto
DOIAbstract
Beta (B.1.351) variant COVID-19 disease was investigated in Qatar. Compared to Alpha (B.1.1.7) variant, odds of progressing to severe disease were 1.24-fold (95% CI: 1.11-1.39) higher for Beta. Odds of progressing to critical disease were 1.49-fold (95% CI: 1.13-1.97) higher. Odds of COVID-19 death were 1.57-fold (95% CI: 1.03-2.43) higher
Add to ORKG